Dietary Phytoestrogens, Complementary and Alternative Medicine, and Lifestyle in Predicting Survival of Women With Breast Cancer

NCT00691509 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2300

Last updated 2013-08-26

No results posted yet for this study

Summary

RATIONALE: Eating a diet rich in phytoestrogens may slow the growth of breast cancer cells and prevent further tumor progression. Learning about the lifestyles of women with breast cancer, their intake of phytoestrogens derived from food and supplements, and their use of complementary or alternative medicine (CAM) practices may help doctors learn more about breast cancer.

PURPOSE: This clinical trial is studying the effect of dietary and supplemental phytoestrogens and CAM therapies in preventing progression and improving survival of women with breast cancer.

Conditions

Interventions

GENETIC

gene expression analysis

GENETIC

polymorphism analysis

OTHER

high performance liquid chromatography

OTHER

laboratory biomarker analysis

OTHER

mass spectrometry

OTHER

questionnaire administration

Sponsors & Collaborators

  • University College London Hospitals

    lead OTHER

Principal Investigators

  • Anthony Leathem, MD · University College London Hospitals

Eligibility

Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-01-31
Primary Completion
2010-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00691509 on ClinicalTrials.gov